Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis
Table 3
Comparison of co-medication usage in primary vs. secondary prophylaxis and Child-Pugh A vs. Child-Pugh B/C.